Home > Products > CD3 & IGF1R
> Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (IgG-Fv)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (IgG-Fv) (CAT#: BSGV-092)
Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CD3 antibody variable domain is fused to the C terminal of an IgG of anti-IGF1R antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Melanoma; Colon cancer; Pancreas cancer; Prostate cancer; Kidney cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-IGF1R Bispecific Antibody (IgG-Fv) (BSGV-092). Click the button below to contact us or submit your feedback about this product.